MediWound Ltd. held its 2026 annual shareholder meeting on May 6, 2026, where all proposals, including director re-elections, auditor reappointment, and CEO bonus approval, passed with overwhelming majorities.
Key takeaways
All five director nominees—Nachum Shamir, Dr. Vickie R. Driver, David Fox, Shmuel (Milky) Rubinstein, and Stephen T. Wills—re-elected with 99.0-99.5% votes in favor.
Somekh Chaikin (KPMG member firm) reappointed as independent auditor for year ending December 31, 2026, with 99.8% approval.
CEO Ofer Gonen's 2025 annual cash bonus approved with 99.5% majority, meeting special majority requirements under Companies Law.
Meeting quorum achieved with 6,208,465 ordinary shares (48.3% of outstanding) present in person or by proxy.